Tissue Array
Log In | My Account | Cart (0 items) - $0.00
US Biomax, Inc.
 

OV1005

Ovarian disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases/100 cores, replaced by OV1005a
Unstained: $225.00 Add to Cart
H&E (OV1005s*): $225.00 Add to Cart

Microarray Panel:Ovarian disease spectrum (ovarian cancer progression) tissue microarray, containing 27 cases of serous adenocarcinoma, 3 mucinous adenocarcinoma, 10 endometrioid adenocarcinoma, 5 transitional cell carcinoma, 10 metastatic carcinoma, 25 adenoma, 12 adjacent normal tissue and 8 normal tissue, single core per case
Cores:100
Cases:100
Layout:10 cols × 10 rows
Core Diameter:1 mm
Thickness:5 µm
Quality Control:Anti-Actin confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H & E: Hematoxylin and Eosin stained tissue microarray slide.

Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
12345678910 
A Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova  
B Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova  
C Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova  
D Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova  
E Ova Ova Ova Ova Ova Mes Mes Epi Epi Epi  
F Epi Epi Epi Per Per Ova Ova Ova Ova Ova  
G Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova  
H Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova  
I Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova  
J Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova Marked point
Legend: Epi - Epiploon, Mes - Mesentery, Ova - Ovary, Per - Peritoneum

- Benign tumor, - Borderline, - Malignant tumor, - Malignant tumor (stage I), - Malignant tumor (stage II), - Malignant tumor (stage IIIc), - Malignant tumor (stage IIa), - Malignant tumor (stage IIb), - Malignant tumor (stage IV), - Malignant tumor (stage Ia), - Malignant tumor (stage Ib), - Malignant tumor (stage Ic), - Metastasis, - NAT, - Normal tissue

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 F 65 Ovary Serous papillary cystadenocarcinoma 1 I T1N0M0 Malignant
A2 2 F 38 Ovary Serous papillary cystadenocarcinoma 1 IV T3cN1M1 Malignant
A3 3 F 51 Ovary Serous papillary cystadenocarcinoma 1 IIIc T3cN1M0 Malignant
A4 4 F 22 Ovary Serous papillary cystadenocarcinoma 1 IIb T2bN0M0 Malignant
A5 5 F 48 Ovary Serous papillary cystadenocarcinoma 1 I T1N0M0 Malignant
A6 6 F 26 Ovary Serous papillary cystadenocarcinoma 1 IIIc T3cN1M0 Malignant
A7 7 F 25 Ovary Serous papillary cystadenocarcinoma 1 I T1N0M0 Malignant
A8 8 F 50 Ovary Serous papillary cystadenocarcinoma 1 II T2N0M0 Malignant
A9 9 F 26 Ovary Serous papillary cystadenocarcinoma 1 Ic T1cN0M0 Malignant
A10 10 F 47 Ovary Serous papillary cystadenocarcinoma 1 I T1N0M0 Malignant
B1 11 F 58 Ovary Serous papillary adenocarcinoma 2 I T1N0M0 Malignant
B2 12 F 57 Ovary Serous papillary cystadenocarcinoma 2 Ic T1cN0M0 Malignant
B3 13 F 51 Ovary Serous papillary adenocarcinoma 2 Ia T1aN0M0 Malignant
B4 14 F 52 Ovary Serous papillary cystadenocarcinoma 2 II T2N0M0 Malignant
B5 15 F 54 Ovary Serous papillary adenocarcinoma 2 IIIc T3cN1M0 Malignant
B6 16 F 33 Ovary Serous papillary adenocarcinoma 2 I T1N0M0 Malignant
B7 17 F 56 Ovary Serous papillary adenocarcinoma 2 II T2N0M0 Malignant
B8 18 F 41 Ovary Serous papillary adenocarcinoma 2 I T1N0M0 Malignant
B9 19 F 50 Ovary Serous papillary adenocarcinoma 2 I T1N0M0 Malignant
B10 20 F 46 Ovary Serous papillary adenocarcinoma (sparse) 2 IIIc T2cN1M0 Malignant
C1 21 F 57 Ovary Serous adenocarcinoma 2–3 IIIc T3cN1M0 Malignant
C2 22 F 75 Ovary Serous adenocarcinoma 2 II T2N0M0 Malignant
C3 23 F 54 Ovary Serous adenocarcinoma 2 IIIc T3cN0M0 Malignant
C4 24 F 49 Ovary Serous papillary adenocarcinoma 2 II T2N0M0 Malignant
C5 25 F 46 Ovary Serous papillary adenocarcinoma 2–3 IIIc T3aN1M0 Malignant
C6 26 F 52 Ovary Serous adenocarcinoma 3 II T2N0M0 Malignant
C7 27 F 47 Ovary Serous adenocarcinoma 3 Ic T1cN0M0 Malignant
C8 28 F 34 Ovary Mucinous adenocarcinoma 1 Ib T1bN0M0 Malignant
C9 29 F 63 Ovary Mucinous adenocarcinoma 1 Ia T1aN0M0 Malignant
C10 30 F 69 Ovary Mucinous adenocarcinoma 1 Ib T1bN0M0 Malignant
D1 31 F 55 Ovary Endometrioid adenocarcinoma 2 I T1N0M0 Malignant
D2 32 F 55 Ovary Endometrioid adenocarcinoma 2 I T1N0M0 Malignant
D3 33 F 47 Ovary Endometrioid adenocarcinoma 1–2 IIa T2aN0M0 Malignant
D4 34 F 53 Ovary Endometrioid adenocarcinoma 3 IIa T2aN0M0 Malignant
D5 35 F 50 Ovary Endometrioid adenocarcinoma 3 IIIc T3bN1M0 Malignant
D6 36 F 54 Ovary Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
D7 37 F 43 Ovary Endometrioid adenocarcinoma 1 Ic T1cN0M0 Malignant
D8 38 F 41 Ovary Endometrioid adenocarcinoma 1–2 Ia T1aN0M0 Malignant
D9 39 F 50 Ovary Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
D10 40 F 46 Ovary Endometrioid adenocarcinoma 1 II T2N0M0 Malignant
E1 41 F 51 Ovary Transitional cell carcinoma 2 Ib T1bN0M0 Malignant
E2 42 F 39 Ovary Transitional cell carcinoma 2 Ia T1aN0M0 Malignant
E3 43 F 38 Ovary Transitional cell carcinoma 2 I T1N0M0 Malignant
E4 44 F 66 Ovary Transitional cell carcinoma with squamous metaplasia 3 Ia T1aN0M0 Malignant
E5 45 F 53 Ovary Transitional cell carcinoma 2–3 I T1N0M0 Malignant
E6 46 F 47 Mesentery Metastatic serous papillary cystadenocarcinoma from ovary 1 – – Metastasis
E7 47 F 59 Mesentery Metastatic serous papillary cystadenocarcinoma with calcification from ovary 1 – – Metastasis
E8 48 F 28 Epiploon Metastatic serous papillary cystadenocarcinoma with calcification from ovary 1 – – Metastasis
E9 49 F 65 Epiploon Metastatic serous papillary cystadenocarcinoma from ovary 2 – – Metastasis
E10 50 F 64 Epiploon Metastatic serous adenocarcinoma from ovary 2 – – Metastasis
F1 51 F 50 Epiploon Metastatic serous papillary cystadenocarcinoma from ovary 1 – – Metastasis
F2 52 F 57 Epiploon Metastatic serous papillary cystadenocarcinoma from ovary 1 – – Metastasis
F3 53 F 58 Epiploon Metastatic adenocarcinoma from ovary 3 – – Metastasis
F4 54 F 47 Peritoneum Metastatic adenocarcinoma from ovary 3 – – Metastasis
F5 55 F 49 Peritoneum Metastatic adenocarcinoma from ovary 3 – – Metastasis
F6 56 F 34 Ovary Borderline serous papillary cystadenoma – – – Borderline
F7 57 F 28 Ovary Borderline serous papillary cystadenoma – – – Borderline
F8 58 F 22 Ovary Borderline serous papillary cystadenoma – – – Borderline
F9 59 F 53 Ovary Borderline serous papillary cystadenoma – – – Borderline
F10 60 F 69 Ovary Borderline serous papillary cystadenoma – – – Borderline
G1 61 F 50 Ovary Borderline mucinous papillary cystadenoma – – – Borderline
G2 62 F 37 Ovary Borderline mucinous papillary cystadenoma – – – Borderline
G3 63 F 62 Ovary Serous cystadenoma – – – Benign
G4 64 F 22 Ovary Serous cystadenoma – – – Benign
G5 65 F 49 Ovary Serous cystadenoma – – – Benign
G6 66 F 22 Ovary Serous cystadenoma – – – Benign
G7 67 F 16 Ovary Serous cystadenoma – – – Benign
G8 68 F 34 Ovary Serous cystadenoma – – – Benign
G9 69 F 19 Ovary Mucinous cystadenoma – – – Benign
G10 70 F 18 Ovary Mucinous cystadenoma – – – Benign
H1 71 F 29 Ovary Mucinous cystadenoma – – – Benign
H2 72 F 32 Ovary Mucinous cystadenoma (ovary tissue) – – – Benign
H3 73 F 26 Ovary Mucinous cystadenoma (ovary tissue) – – – Benign
H4 74 F 70 Ovary Mucinous cystadenoma (mucous tissue) – – – Benign
H5 75 F 22 Ovary Mucinous cystadenoma (ovary tissue) – – – Benign
H6 76 F 33 Ovary Mucinous cystadenoma – – – Benign
H7 77 F 38 Ovary Mucinous cystadenoma (ovary tissue) – – – Benign
H8 78 F 51 Ovary Mucinous cystadenoma – – – Benign
H9 79 F 17 Ovary Mucinous cystadenoma – – – Benign
H10 80 F 35 Ovary Mucinous cystadenoma (ovary tissue) – – – Benign
I1 81 F 30 Ovary Cancer adjacent normal ovarian tissue – – – NAT
I2 82 F 39 Ovary Cancer adjacent normal ovarian tissue – – – NAT
I3 83 F 29 Ovary Cancer adjacent normal ovarian tissue – – – NAT
I4 84 F 40 Ovary Cancer adjacent normal ovarian tissue – – – NAT
I5 85 F 40 Ovary Cancer adjacent normal ovarian tissue – – – NAT
I6 86 F 63 Ovary Cancer adjacent normal ovarian tissue – – – NAT
I7 87 F 45 Ovary Cancer adjacent normal ovarian tissue – – – NAT
I8 88 F 38 Ovary Cancer adjacent normal ovarian tissue – – – NAT
I9 89 F 53 Ovary Cancer adjacent normal ovarian tissue – – – NAT
I10 90 F 42 Ovary Cancer adjacent normal ovarian tissue – – – NAT
J1 91 F 57 Ovary Cancer adjacent normal ovarian tissue (mucinous cystadenocarcinoma) 2–3 – – NAT
J2 92 F 38 Ovary Cancer adjacent normal ovarian tissue – – – NAT
J3 93 F 18 Ovary Normal ovarian tissue – – – Normal
J4 94 F 20 Ovary Normal ovarian tissue – – – Normal
J5 95 F 19 Ovary Normal ovarian tissue – – – Normal
J6 96 F 15 Ovary Normal ovarian tissue – – – Normal
J7 97 F 18 Ovary Normal ovarian tissue – – – Normal
J8 98 F 21 Ovary Normal ovarian tissue – – – Normal
J9 99 F 41 Ovary Normal ovarian tissue – – – Normal
J10 100 F 27 Ovary Normal ovarian tissue – – – Normal
– – M 58 Skin Malignant melanoma (tissue marker) – Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array:
© 2003 - 2011 US Biomax Inc., custsrv@biomax.us, Tel: (800) 935-1357 | Privacy Policy

Authorize.Net Seal Starfield Seal